297a-coc-redacted

Dieses Dokument ist Teil der Anfrage „Briefverkehr mit BioNtech

/ 1
PDF herunterladen
BioNTech Manufacturing GmbH SIONTZCTHA

Manufacturing
An der Goldgrube 12

55131 Mainz, Germany

phone: +49-6131-9084-0

fax: +49-6131-9084-390

Certificate of Compliance

 

 

 

 

 

 

 

 

   
  
  
   

 

 

 

 
  

 

(No.: )

Product: COMIRNATYTM
Lot/Batch No.:
Date of Manufacture 03 Dec 2021 \

| Batch size: j

| Packaging: GC-Vial 2 mL (10 vials/pack) |
Strength/Potency: 30 ug BNT162b2 per dose (0.3 mL)
Volume per vial: 2.25 mL
Dosage Form: Dispersion for i.m. injection —
Retest date/Expiry date: 31 May 2022 - |
Destination: All EU Member States, Norway, Iceland and Liechtenstein
Authorization No.: EU/1/20/1528/002

 

 

 
  
   
 

Name and Address of
Manufacturer (OP release):

Manufacturing authorization
number /GMP-Certificate:

Pa
Remarks: N/A

Certification Statement:

I hereby certify that allthe manufacturing stages of this batch of finished product have

been carried out in full compliance with the GMP requirements ofthe EU and with the

requirements ofthe EU Marketing Authorisation.

2 1 JAN 2022

Date, Signature ofthe Qualified Person
1